Polyrizon Hires Branding Firm for Brand Development
02 Apr 2025 //
GLOBENEWSWIRE
Polyrizon Closes $17.0M Private Placement
01 Apr 2025 //
GLOBENEWSWIRE
Polyrizon Ltd. Announces $17.0 Million Private Placement
31 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Plans Clinical Strategy For Allergy Blocker Before FDA
27 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Expands Drug Delivery With Preclinical Epilepsy Study
25 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Signs LOI to Expand Intranasal Delivery for Psychedelic
14 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Starts Preclinical Studies for Intranasal Naloxone
13 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Files Annual Report on Form 20-F for 2024
11 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Starts Preclinical Studies For Intranasal Naloxone
10 Mar 2025 //
GLOBENEWSWIRE
Polyrizon Files Divisional Patent For Trap & Intranasal Platform
30 Jan 2025 //
GLOBENEWSWIRE
Polyrizon Prepare GMP Manufacturing For PL-14 Allergy Blocker Trial
23 Jan 2025 //
GLOBENEWSWIRE